ES268064A1 - A method for the production of 3-ceto-delta4,6-6-trifluorometilo steroids and 3-ceto-delta1,4,6-6-trifluoromethyl esteroids of the androstano series, of the 19-nor-androstano series and of the 19-nor-pregnano series (Machine-translation by Google Translate, not legally binding) - Google Patents
A method for the production of 3-ceto-delta4,6-6-trifluorometilo steroids and 3-ceto-delta1,4,6-6-trifluoromethyl esteroids of the androstano series, of the 19-nor-androstano series and of the 19-nor-pregnano series (Machine-translation by Google Translate, not legally binding)Info
- Publication number
- ES268064A1 ES268064A1 ES0268064A ES268064A ES268064A1 ES 268064 A1 ES268064 A1 ES 268064A1 ES 0268064 A ES0268064 A ES 0268064A ES 268064 A ES268064 A ES 268064A ES 268064 A1 ES268064 A1 ES 268064A1
- Authority
- ES
- Spain
- Prior art keywords
- series
- androstano
- ceto
- trifluoromethyl
- steroids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
A method for the production of 3-keto Δ 4,6-6-trifluoromethyl steroids and 3-keto- Δ 1,4,6-6-trifluoromethyl steroids of the androstane series, of the 19-nor-androstane series , and of the pregnane series, and the 19-nor-pregnane series, characterized in that the 3-keto- Δ 4-6- α -trifluoromethyl steroid of one of said series, in which the group of 3- keto has been transformed into a cyclic ketal group is reacted with N-bromosuccinamide, in which the reaction product is dehydrobrominated and subsequently the ketal group is removed by acid hydrolysis after which if it is desired to achieve a 3-ketocyte steroid Δ 1,4,6-6-trifluoromethyl, the 3-keto- Δ 4,6-6-trifluoromethyl steroid thus obtained is dehydrogenated in the manner known per se. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2019060 | 1960-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES268064A1 true ES268064A1 (en) | 1961-11-16 |
Family
ID=10141901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES0268064A Expired ES268064A1 (en) | 1960-06-08 | 1961-06-08 | A method for the production of 3-ceto-delta4,6-6-trifluorometilo steroids and 3-ceto-delta1,4,6-6-trifluoromethyl esteroids of the androstano series, of the 19-nor-androstano series and of the 19-nor-pregnano series (Machine-translation by Google Translate, not legally binding) |
Country Status (3)
Country | Link |
---|---|
CH (1) | CH401960A (en) |
DK (1) | DK102857C (en) |
ES (1) | ES268064A1 (en) |
-
1961
- 1961-06-08 DK DK232161A patent/DK102857C/en active
- 1961-06-08 CH CH668161A patent/CH401960A/en unknown
- 1961-06-08 ES ES0268064A patent/ES268064A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DK102857C (en) | 1965-10-18 |
CH401960A (en) | 1965-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES301833A1 (en) | A procedure for the preparation of 19-alkil-steroids (Machine-translation by Google Translate, not legally binding) | |
ES268064A1 (en) | A method for the production of 3-ceto-delta4,6-6-trifluorometilo steroids and 3-ceto-delta1,4,6-6-trifluoromethyl esteroids of the androstano series, of the 19-nor-androstano series and of the 19-nor-pregnano series (Machine-translation by Google Translate, not legally binding) | |
ES423481A1 (en) | Processes and intermediates for 16-substituted corticoid synthesis | |
ES265825A1 (en) | A method for the production of 3-ceto-delta-4,6-alpha-trifluoromethyl-steroids and 3-ceto-delta-1,4-6 alpha-trifluoromethyl-steroids of the androstano series, of the pergnano series, of the 19-nor-androstano series and the 19-nor-pregnano series and their 3-nor-esteres (Machine-translation by Google Translate, not legally binding) | |
GB802566A (en) | Improvements in or relating to a steroid and the manufacture thereof | |
GB1011573A (en) | Process for the manufacture of 19-nor-steroids | |
GB967006A (en) | Improvements in or relating to steroids | |
GB1185381A (en) | 05,16beta-Methylene Steroids of the 19-Nor-Androstane Series and Process for their Manufacture | |
GB916951A (en) | New process for the preparation of 6ª--fluoro-steroids | |
GB946874A (en) | New steroid compounds, and processes for the preparation thereof | |
ES364018A1 (en) | 18-methyl-5alpha-h-androstane derivatives and process of making the same | |
GB934711A (en) | New steroid compounds and processes for their preparation and conversion into substituted corticosteroids | |
ES259017A1 (en) | Improvements in or relating to processes for the production of steroid compounds and the compounds thus produced | |
GB955613A (en) | New steroid compounds and processes | |
GB802618A (en) | Improvements in or relating to a steroid and the manufacture thereof | |
GB940344A (en) | Process for the manufacture of unsaturated steroids | |
GB948114A (en) | Steroids and production thereof | |
GB804523A (en) | Steroids and the preparation thereof | |
ES245396A1 (en) | Procedure for obtaining steroids (Machine-translation by Google Translate, not legally binding) | |
GB894168A (en) | New steroid compounds and processes for their production | |
ES343874A1 (en) | 6-substituted derivatives of 16-methyl-4-pregnene-3beta-ol-one | |
ES250766A1 (en) | Chemical procedure for the obtaining of new esteroid compounds of the pregnant series (Machine-translation by Google Translate, not legally binding) | |
GB862701A (en) | A process for the preparation of 9ª‡-hydroxy steroids | |
FR1212872A (en) | Process for preparing steroids of the pregnane series, in particular a 16-alpha, 21-dialkanoyloxy-17-alpha-hydroxy-4, 9 (11) -prégnadiene-3, 20-dione | |
GB966100A (en) | Novel cyclopentanophenanthrene compounds and a process for the production thereof |